JP2013533867A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013533867A5 JP2013533867A5 JP2013516930A JP2013516930A JP2013533867A5 JP 2013533867 A5 JP2013533867 A5 JP 2013533867A5 JP 2013516930 A JP2013516930 A JP 2013516930A JP 2013516930 A JP2013516930 A JP 2013516930A JP 2013533867 A5 JP2013533867 A5 JP 2013533867A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- glutamine
- dipeptide
- source
- organogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 108010016626 Dipeptides Proteins 0.000 claims 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 4
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims 2
- 229960002648 alanylglutamine Drugs 0.000 claims 2
- 206010023330 Keloid scar Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35905310P | 2010-06-28 | 2010-06-28 | |
| US61/359,053 | 2010-06-28 | ||
| PCT/CA2011/050396 WO2012000113A1 (en) | 2010-06-28 | 2011-06-28 | Keloid treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013533867A JP2013533867A (ja) | 2013-08-29 |
| JP2013533867A5 true JP2013533867A5 (enExample) | 2014-08-14 |
Family
ID=45401271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013516930A Pending JP2013533867A (ja) | 2010-06-28 | 2011-06-28 | ケロイド治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20140005116A1 (enExample) |
| EP (1) | EP2585090A4 (enExample) |
| JP (1) | JP2013533867A (enExample) |
| KR (1) | KR20130089174A (enExample) |
| CN (1) | CN103002903B (enExample) |
| AU (1) | AU2011274224A1 (enExample) |
| BR (1) | BR112012033349A2 (enExample) |
| CA (1) | CA2804413A1 (enExample) |
| CO (1) | CO6680624A2 (enExample) |
| MX (1) | MX2013000107A (enExample) |
| RU (1) | RU2578426C2 (enExample) |
| WO (1) | WO2012000113A1 (enExample) |
| ZA (1) | ZA201209759B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12318406B2 (en) | 2013-03-15 | 2025-06-03 | Cda Research Group, Inc. | Methods of treatment using topical copper ion formulations |
| US11000545B2 (en) | 2013-03-15 | 2021-05-11 | Cda Research Group, Inc. | Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza |
| US11318089B2 (en) | 2013-03-15 | 2022-05-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body |
| US10398733B2 (en) | 2013-03-15 | 2019-09-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body |
| FR3004353B1 (fr) * | 2013-04-10 | 2015-05-15 | Fabre Pierre Dermo Cosmetique | Association synergique de l'alanine-glutamine, l'acide hyaluronique et un extrait d'avoine, et son utilisation dans une composition destinee a la cicatrisation et la reparation des lesions cutanees |
| KR101800788B1 (ko) * | 2017-03-31 | 2017-11-27 | 박영오 | 켈로이드 흉터 개선용 화장료 조성물 |
| US10500318B1 (en) * | 2018-07-03 | 2019-12-10 | Temple Therapeutics BV | Dosing regimens for treating hypoxia-associated tissue damage |
| US11193184B2 (en) | 2019-02-22 | 2021-12-07 | Cda Research Group, Inc. | System for use in producing a metal ion suspension and process of using same |
| CN114767590B (zh) * | 2022-04-20 | 2024-03-15 | 上海交通大学医学院附属第九人民医院 | 一种祛疤祛痘印美容液及其制备方法与应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5740409A (en) * | 1980-08-22 | 1982-03-06 | Mitsui Toatsu Chem Inc | Remedy for disease caused by extraordinary propagation of collagen |
| US6149925A (en) * | 1998-11-05 | 2000-11-21 | Color Access, Inc. | Topical compositions for enhancing glutathione production |
| AU7067200A (en) * | 1999-08-23 | 2001-03-19 | Organogenesis Inc. | Skin care compositions and treatments |
| WO2002087576A1 (en) * | 2001-04-30 | 2002-11-07 | Arachnova Therapeutics Ltd. | The treatment of scarring and related conditions using ppar-gamma activators |
| US20030105025A1 (en) * | 2001-10-31 | 2003-06-05 | Fortuna Haviv | Tri-and tetrapeptides having antiangiogenic activity |
| RU2234963C2 (ru) * | 2002-09-16 | 2004-08-27 | Сибирский государственный медицинский университет | Способ лечения гипертрофических и келоидных кожных рубцов |
| AU2004279314B2 (en) * | 2003-09-12 | 2010-12-09 | The Regents Of The University Of Colorado, A Body Corporate | Glutamine for use in treating injury |
| RU2275216C1 (ru) * | 2004-12-08 | 2006-04-27 | Елена Григорьевна Арий | Способ профилактики формирования патологических кожных рубцов |
| AU2006279218B2 (en) * | 2005-08-11 | 2013-05-02 | Adetherapeutics, Inc. | Reducing post-operative adhesion formation with intraperitoneal glutamine |
| WO2007056068A2 (en) * | 2005-11-02 | 2007-05-18 | Bentley Pharmaceuticals, Inc. | Macrocyclic formulations for transmembrane drug delivery |
| CN100372522C (zh) * | 2005-12-02 | 2008-03-05 | 何秋莎 | 护肤品 |
| CA2578647A1 (en) * | 2007-02-15 | 2008-08-15 | University Of Saskatchewan | Reducing post-operative adhesion formation with intraperitoneal glutamine |
-
2011
- 2011-06-28 CA CA2804413A patent/CA2804413A1/en not_active Abandoned
- 2011-06-28 BR BR112012033349A patent/BR112012033349A2/pt not_active IP Right Cessation
- 2011-06-28 MX MX2013000107A patent/MX2013000107A/es not_active Application Discontinuation
- 2011-06-28 KR KR1020127034180A patent/KR20130089174A/ko not_active Withdrawn
- 2011-06-28 WO PCT/CA2011/050396 patent/WO2012000113A1/en not_active Ceased
- 2011-06-28 US US13/807,378 patent/US20140005116A1/en not_active Abandoned
- 2011-06-28 AU AU2011274224A patent/AU2011274224A1/en not_active Abandoned
- 2011-06-28 CN CN201180031168.3A patent/CN103002903B/zh active Active
- 2011-06-28 EP EP11800037.1A patent/EP2585090A4/en not_active Withdrawn
- 2011-06-28 RU RU2013103507/15A patent/RU2578426C2/ru active
- 2011-06-28 JP JP2013516930A patent/JP2013533867A/ja active Pending
-
2012
- 2012-12-21 ZA ZA2012/09759A patent/ZA201209759B/en unknown
-
2013
- 2013-01-28 CO CO13015329A patent/CO6680624A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013533867A5 (enExample) | ||
| IN2014DN09434A (enExample) | ||
| NZ706635A (en) | Inhibitors of histone demethylases | |
| MX365939B (es) | Moduladores del transporte nuclear y usos de los mismos. | |
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2015007900A (es) | Esteroides neuroactivos sustituidos con 19-alcoxi-17, profarmacos de los mismos, y metodos de tratamiento usando los mismos. | |
| MX2022013590A (es) | Metodos y composiciones para el tratamiento de trastorno por deficit de atencion. | |
| PH12015502539B1 (en) | Cenicriviroc compositions and methods of making and using the same | |
| EA201590161A1 (ru) | Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона | |
| JP2015525757A5 (enExample) | ||
| PH12015500746A1 (en) | Benzamides | |
| JO3122B1 (ar) | مشتقات إسترا-5،3،1(10)، 16- تترايين-3- كربوكساميد، عمليات لتحضيرها، مستحضرات دوائية تشتمل عليها واستخدامها لتحضير أدوية | |
| EA201491281A1 (ru) | КОМПОЗИЦИЯ В ФОРМЕ СУХОГО ПОРОШКА, СОДЕРЖАЩАЯ КОРТИКОСТЕРОИД И β-АДРЕНЕРГИЧЕСКОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, ДЛЯ ВВЕДЕНИЯ ИНГАЛЯЦИЕЙ | |
| HK1215190A1 (zh) | 载体连接型前列腺素类前药 | |
| MX347620B (es) | Derivados de sulfonilaminopirrolidinona, su preparacion y aplicacion terapeutica. | |
| EA201591415A1 (ru) | Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии | |
| MX2015008171A (es) | Formulacion que comprende agomelatina amorfa. | |
| JP2017517574A5 (enExample) | ||
| WO2014043243A3 (en) | Platinum compounds, compositions and methods for the treatment of cancer | |
| BR112015004115A2 (pt) | composições farmacêuticas compreendendo flurbiprofeno | |
| UA115307C2 (uk) | Застосування лікарського засобу, що містить рекомбінантний лектин омели для лікування раку шкіри | |
| JP2013147480A5 (enExample) | ||
| EA201590732A1 (ru) | Диспергируемая таблетка | |
| IN2014DN10683A (enExample) |